Clinical features of 54 children infected with SARS-CoV-2 delta variant in Yangzhou area

  • Yuan LYU ,
  • Guihua SHU ,
  • Weiwei HOU ,
  • Xingxing LU ,
  • Min YUAN ,
  • Yueyuan WANG ,
  • Yuehong TAO
Expand
  • Department of Pediatrics, Northern Jiangsu People’s Hospital Affiliated to Yangzhou University, Yangzhou 225000, Jiangsu, China

Received date: 2021-08-31

  Online published: 2022-04-07

Abstract

Objective To investigate the clinical characteristics of SARS-CoV-2 delta variant in children and the similarities and differences between children and adults.Methods The clinical data of 54 children infected with SARS-COV-2 delta variant in Yangzhou were retrospectively analyzed and were compared with those of adults who were diagnosed in the same period.Results There were 35 boys and 19 girls in the children group and the mean age was (8.1±3.4) years. In the adult group, there were 37 patients (23 boys and 14 girls), and the mean age was (33.4±7.6) years. Compared with the adult group, the children group had a higher proportion of mild cases, a lower proportion of vaccination, a lower proportion of respiratory symptoms, a higher level of CK-MB, a lower level of CRP and IL-6, and a lower titer of SARS-CoV-2 IgG and IgM antibodies on admission, and the differences were statistically significant (P<0.05). No antibiotics or glucocorticoids were given in 2 groups. The patients were mainly treated with traditional Chinese medicine, posture therapy and symptomatic treatment, and the prognosis were good. The time from onset to disappearance of clinical symptoms was 4.0 (2.0-7.0) days in the children group and 7.0 (4.2-10.8) days in the adult group, and the difference between the two groups was statistically significant (P<0.01). The peak values of SARS-CoV-2 IgG and IgM antibodies in the children group were lower than those in the adult group, and the differences were statistically significant (P<0.05).Conclusions Children are also susceptible to the SARS-COV-2 delta variant, with a higher proportion of mild infection. Furthermore, children are more likely to have myocardial injury and recover faster than adults.

Cite this article

Yuan LYU , Guihua SHU , Weiwei HOU , Xingxing LU , Min YUAN , Yueyuan WANG , Yuehong TAO . Clinical features of 54 children infected with SARS-CoV-2 delta variant in Yangzhou area[J]. Journal of Clinical Pediatrics, 2022 , 40(4) : 252 -257 . DOI: 10.12372/jcp.2022.21e1264

References

[1] 中华预防医学会新型冠状病毒肺炎防控专家组. 新型冠状病毒肺炎流行病学特征的最新认识[J]. 中华流行病学杂志, 2020, 41(2):139-144.
[2] Maltezou HC, Magaziotou I, Dedoukou X, et al. Children and adolescents with SARS-CoV-2 infection: epidemiology, clinical course and viral loads[J]. Pediatr Infect Dis J, 2020, 39(12):e388-e392.
[3] 蒋荣猛, 谢正德, 姜毅, 等. 儿童新型冠状病毒感染诊断、治疗和预防专家共识(第三版)[J]. 中华实用儿科临床杂志, 2021, 36(10):721-732.
[4] 中华人民共和国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第八版修订版)[J]. 中华临床感染病杂志, 2021, 14(2):81-88.
[5] Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children[J]. Pediatr Infect Dis J, 2020, 39(5):355-368.
[6] Wu H, Zhu H, Yuan C, et al. Clinical and immune features of hospitalized pediatric patients with coronavirus disease 2019 (COVID-19) in Wuhan, China[J]. JAMA Netw Open, 2020, 3(6):e2010895.
[7] Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J]. Lancet, 2020, 395(10229):1054-1062.
[8] Opel DJ, Diekema DS, Ross LF. Should we mandate a COVID-19 vaccine for children?[J]. JAMA Pediatr, 2021, 175(2):125-126.
[9] Liguoro I, Pilotto C, Bonanni M, et al. SARS-COV-2 infection in children and newborns: a systematic review[J]. Eur J Pediatr, 2020, 179(7):1029-1046.
[10] 易兰芬, 邱梅, 文红霞. 新型冠状病毒感染儿童心肌损伤的研究[J]. 临床儿科杂志, 2020, 38(12):905-907.
[11] Iba T, Levy JH, Levi M, et al. Coagulopathy in COVID-19[J]. J Thromb Haemost, 2020, 18(9):2103-2109.
[12] Boehme AK, Doyle K, Thakur KT, et al. Disorders of consciousness in hospitalized patients with COVID-19: the role of the systemic inflammatory response syndrome[J]. Neurocrit Care, 2022, 36(1):89-96.
[13] Mukund K, Mathee K, Subramaniam S. Plasmin cascade mediates thrombotic events in SARS-CoV-2 infection via complement and platelet-activating systems[J]. IEEE Open J Eng Med Biol, 2020, 1:220-227.
Outlines

/